Patents Assigned to UNIVERSITAET REGENSBURG
-
Patent number: 11938233Abstract: 1,7-diaryl-1,6-heptadiene-3,5-dione derivatives, methods for the production and use thereof.Type: GrantFiled: November 3, 2021Date of Patent: March 26, 2024Assignees: UNIVERSITÄTSKLINIKUM REGENSBURG, UNIVERSITÄT SALZBURGInventors: Andreas Späth, Kristjan Plätzer, Tim Maisch, Anja Eichner
-
Publication number: 20230324363Abstract: The invention relates to a device for detecting water flow through or over at least one layer of biological cells, the device containing a first and a second container, the second container being situated at least in part within the first container such that two separate compartments are formed. The base of the second container consists, at least in regions, of a planar, water-permeable substrate for growing biological cells, and the base of the first container has an electrode pair, the electrodes of which each have an electrical connection which leads into a space outside the first container. By means of the device according to the invention, water flow over at least one layer of biological cells can be detected easily, quickly, robustly, and reproducibly, with a high temporal resolution. The invention also relates to a method for detecting water flow over at least one layer of biological cells.Type: ApplicationFiled: August 17, 2021Publication date: October 12, 2023Applicants: FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E. V., UNIVERSITÄT REGENSBURGInventors: Kathrin ZÖPFL, Joachim WEGENER, Florian URBAN
-
Patent number: 11702701Abstract: The present invention relates to methods for diagnosing, staging and treating cancer, in particular melanoma. In particular, the present invention provides methods for determining the stage/type of a cancerous disease, comprising detecting somatic alterations of the DNA of one or more disseminated cancer cells (DCCs), obtained after homing to a distant organ, such as lymph node; and determining the somatic evolution of the DCC(s) based on the detected somatic alterations, wherein the somatic evolution is indicative of the stage/type of the cancerous disease.Type: GrantFiled: January 27, 2017Date of Patent: July 18, 2023Assignees: FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V., UNIVERSITÄT REGENSBURGInventors: Christoph Klein, Sebastian Scheitler, Melanie Werner-Klein, Martin Hoffmann, Isabelle Hodak
-
Patent number: 11578298Abstract: The invention relates to a device designed for the cultivation and radiation-induced killing of living biological cells. The device comprises a flat substrate and a functional layer for creating a wound in biological cells, said functional layer being applied to the flat substrate. The functional layer contains at least one photosensitizer which is designed to convert triplet oxygen into singlet oxygen by the application of electromagnetic radiation. As a result, biological cells on the functional layer can be killed by irradiation of low-intensity electromagnetic radiation. A wound can be introduced into a cell layer at a locally defined point easily, quickly, carefully, and in a flexible and cost-effective manner and thus the healing of the wound can be studied. The invention further relates to uses of the devices and a method for analyzing a migration and/or wound healing behavior of biological cells.Type: GrantFiled: November 6, 2018Date of Patent: February 14, 2023Assignees: Universität Regensburg, Fraunhofer-Gesellschaft zur förderung der angewandten Forschung e.V.Inventors: Joachim Wegener, Carina Schmittlein, Michael Skiba
-
Patent number: 11384076Abstract: The present invention relates to small molecule compounds of formula (I) and their use as FLT3 inhibitors for the treatment of various diseases, such as acute myeloid leukemia (AML). The present invention further relates to methods of synthesizing the compounds and methods of treatment.Type: GrantFiled: August 9, 2018Date of Patent: July 12, 2022Assignees: UNIVERSITÄT REGENSBURG, UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITÄT MAINZInventors: Siavosh Mahboobi, Andreas Sellmer, Herwig Pongratz, Bernardette Pilsl, Oliver Krämer, Thomas Kindler, Mandy Beyer
-
Patent number: 11198694Abstract: The present invention relates to small molecule compounds and their use as HDAC inhibitors and their use in the treatment of various diseases, such as cancer. The present invention further relates to methods for improvement of solubility by introducing basic substituents which offer the opportunity to create pharmaceutically acceptable salts. Moreover, it comprises methods of synthesizing the compounds and methods of treatment.Type: GrantFiled: June 29, 2018Date of Patent: December 14, 2021Assignee: UNIVERSITÄT REGENSBURGInventors: Siavosh Mahboobi, Herwig Pongratz, Elisabeth Grünstein
-
Publication number: 20210371795Abstract: The invention relates to a device designed for the cultivation and radiation-induced killing of living biological cells. The device comprises a flat substrate and a functional layer for creating a wound in biological cells, said functional layer being applied to the flat substrate. The functional layer contains at least one photosensitizer which is designed to convert triplet oxygen into singlet oxygen by the application of electromagnetic radiation. As a result, biological cells on the functional layer can be killed by irradiation of low-intensity electromagnetic radiation. A wound can be introduced into a cell layer at a locally defined point easily, quickly, carefully, and in a flexible and cost-effective manner and thus the healing of the wound can be studied. The invention further relates to uses of the devices and a method for analyzing a migration and/or wound healing behavior of biological cells.Type: ApplicationFiled: November 6, 2018Publication date: December 2, 2021Applicants: FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E. V., UNIVERSITÄT REGENSBURGInventors: Joachim WEGENER, Carina SCHMITTLEIN, Michael SKIBA
-
Patent number: 10895546Abstract: The present disclosure relates to a measuring device with a bipolar electrode array for the impedimetric analysis of adherent cells according to the ECIS principle (electric cells substrate impedance sensing). The measuring device comprises an electrode array which is adapted for being wetted with an electrolyte solution and adherently growing cells in order to perform impedimetric cell analyzes, characterized in that the electrode array comprises a bipolar electrode on a substrate, where the bipolar electrode is formed as a conductive path on the transparent substrate and has an inherent resistance between two connection points of the conductive path that is a multiple of the AC impedance of the electrolyte solution at 1 MHz, measured at the two connection points.Type: GrantFiled: December 12, 2017Date of Patent: January 19, 2021Assignees: FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V., UNIVERSITAET REGENSBURGInventors: Christian Goetz, Joachim Wegener
-
Publication number: 20200238281Abstract: A method for producing an apparatus for the sensor-based examination of biological cells is presented. The method comprises equipping at least one sterile vessel, which has an opening and a base which is planar at least in certain regions, with at least one sensor for examining biological cells. After the sterile vessel has been equipped with the sensor, a liquid cryopreservation medium, which contains biological cells, is applied to a surface of the at least one sensor in the at least one vessel. The liquid cryopreservation medium, which contains biological cells, is then frozen. An apparatus produced in this manner allows a more economical and less error-prone sensor-based examination of biological cells and the transport and storage thereof in said apparatus until the time of examination. Uses of the apparatus are proposed.Type: ApplicationFiled: September 28, 2018Publication date: July 30, 2020Applicants: FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E. V., UNIVERSITÄT REGENSBURGInventors: Joachim WEGENER, Stefanie MICHAELIS
-
Patent number: 10514358Abstract: The invention relates to a method which realizes a two-dimensional separation of ionic species on the basis of the online coupling of ion chromatography (IC) and capillary electrophoresis (CE). A device for IC×CE coupling, its implementation in terms of two alternatives, the connection to a mass spectrometric detector, and corresponding application are described.Type: GrantFiled: April 23, 2015Date of Patent: December 24, 2019Assignee: UNIVERSITÄT REGENSBURGInventors: Frank-Michael Matysik, Andrea Beutner, Jonas Mark, Sven Kochmann
-
Publication number: 20190111168Abstract: A photosensitizer-containing dispersion, and use thereof.Type: ApplicationFiled: March 31, 2017Publication date: April 18, 2019Applicants: Universität Regensburg, Universitätsklinikum RegensburgInventors: Wolfgang BÄUMLER, Christiane JUNG, Burkhard KÖNIG, Werner KUNZ, Eva MÜLLER, Andreas SPÄTH
-
Patent number: 10106540Abstract: The present invention relates to small molecule compounds and their use as HDAC inhibitors and in the treatment of various diseases, such as cancer. The present invention further relates to methods of synthesizing the compounds and methods of treatment. H-L(HA), H is a head group selected from (head group 1), (head group 2), (head group 3), (head group 4), (head group 5) and (head group 6).Type: GrantFiled: August 4, 2015Date of Patent: October 23, 2018Assignees: UNIVERSITÄT REGENSBURG, FRIEDRICH-SCHILLER-UNIVERSITÄT JENA, UNIVERSITÄTSKLINIKUM JENAInventors: Siavosh Mahboobi, Andreas Sellmer, Herwig Pongratz, Michel Leonhardt, Oliver Krämer, Frank-Dietmar Böhmer, Gerhard Kelter
-
Patent number: 9700509Abstract: The present invention relates to a solution containing at least one water-miscible biocompatible solvent and a lipophilic substance dissolved therein, wherein upon contact with aqueous body fluid the dissolved lipophilic substance is precipitated out of the solution in the form of nanoparticles and a nanosuspension is formed.Type: GrantFiled: November 27, 2009Date of Patent: July 11, 2017Assignee: UNIVERSITÄT REGENSBURGInventors: Achim Göpferich, Christoph Luschmann
-
Patent number: 9579394Abstract: The subject-matter of the present invention are nanocomplexes of polyanions and cationic peptides which are, e.g., suitable for the transport of drugs into cells and their controlled release in the organism, as well as a complex material in which the nanocomplexes are bonded to a biologically active unit for the selective recognition of tissues, cells or organelles.Type: GrantFiled: August 7, 2012Date of Patent: February 28, 2017Assignee: UNIVERSITAET REGENSBURGInventors: Achim Goepferich, Matthias Ferstl
-
Patent number: 9364370Abstract: The invention relates to an implantable device for the non-pneumatic adjustable positioning of a human or animal body part, comprising a) at least one elastic element and, optionally, b) an abutment, as well as the use of this device in a method for the treatment of disorders that are caused by the deficient or inadequate positioning of a human or animal body part. In particular, the invention relates to the use of the device for treating sleep-related breathing disorders.Type: GrantFiled: January 4, 2006Date of Patent: June 14, 2016Assignee: Klinikum der Universität RegensburgInventor: Thomas Kühnel
-
Patent number: 8927750Abstract: The present invention provides acyloxy- and phosphoryloxy-butadiene-Fe(CO)3 complexes which can deliver carbon monoxide to a physiological target, wherein release of carbon monoxide can be enzymatically-triggered. The present invention also provides for methods of manufacturing the enzymatically-triggered carbon monoxide releasing molecules and methods for their use.Type: GrantFiled: February 4, 2011Date of Patent: January 6, 2015Assignees: Universitaet Zu Koeln, Universitaet RegensburgInventors: Hans-Guenther Schmalz, Steffen Romanski, Sabine Amslinger, Benito Yard, Birgit Kraus
-
Publication number: 20140171368Abstract: The subject-matter of the present invention are nanocomplexes of polyanions and cationic peptides which are, e.g., suitable for the transport of drugs into cells and their controlled release in the organism, as well as a complex material in which the nanocomplexes are bonded to a biologically active unit for the selective recognition of tissues, cells or organelles.Type: ApplicationFiled: August 7, 2012Publication date: June 19, 2014Applicant: UNIVERSITAET REGENSBURGInventors: Achim Goepferich, Matthias Ferstl
-
Publication number: 20140094588Abstract: The present invention relates to a method of predicting the course of disease in a patient having a malignant melanoma, the method comprising determining in melanoma cells comprised in a sample obtained from said malignant melanoma the presence or amount of at least five biomarkers selected from the group comprising or consisting of MTAP, PTEN, Bax, Bcl-X, ?-Catenin, CD20, Cox-2, CD49d and MLH1, wherein the absence or decreased amount of MTAP and ?-Catenin and/or the presence or increased amount of PTEN, Bax, Bcl-X, CD20, Cox-2, CD49d and MLH1, is associated with a disadvantageous course of disease.Type: ApplicationFiled: March 30, 2012Publication date: April 3, 2014Applicants: Universität RegensburgInventors: Stefanie Meyer, Anja Bosserhoff, Peter Wild, Thomas Fuchs
-
Publication number: 20120202774Abstract: The present invention provides acyloxy- and phosphoryloxy-butadiene-Fe(CO)3 complexes which can deliver carbon monoxide to a physiological target, wherein release of carbon monoxide can be enzymatically-triggered. The present invention also provides for methods of manufacturing the enzymatically-triggered carbon monoxide releasing molecules and methods for their use.Type: ApplicationFiled: February 4, 2011Publication date: August 9, 2012Applicants: UNIVERSITAET REGENSBURG, UNIVERSITAET ZU KOELNInventors: Hans-Guenther Schmalz, Steffen Romanski, Sabine Amslinger, Benito Yard, Birgit Kraus
-
Publication number: 20110294745Abstract: The present invention relates to a solution containing at least one water-miscible biocompatible solvent and a lipophilic substance dissolved therein, wherein upon contact with aqueous body fluid the dissolved lipophilic substance is precipitated out of the solution in the form of nanoparticles and a nanosuspension is formed.Type: ApplicationFiled: November 27, 2009Publication date: December 1, 2011Applicant: UNIVERSITÄT REGENSBURGInventors: Achim Göpferich, Christoph Luschmann